Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Financial Media Group (FMG) was a diversified financial media and investor relations company that primarily served small-cap and mid-cap publicly traded companies, including many in the biotechnology and healthcare sectors. The company operated several digital platforms, most notably WallSt.net, which provided business news, multimedia content, and investor awareness programs. While not a life sciences company itself, FMG was a significant service provider in the biotech ecosystem, facilitating communication between emerging healthcare firms and the investment community. The company's assets were eventually acquired by Discovery Data in 2018, integrating its financial professional databases into a larger market intelligence platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Financial Media Group.